4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000170
EVP & Chief Financial Officer sold 3,250 shares at $460.00 ($1,495,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WAGNER CHARLES F JR · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-03 | Sale : show line 1 in the form 10b5-1 | −3,250 | $460.00 | $1,495,000 | 47,137 | D |
| Open-market sales · 3,250 sh · avg $460.00 · $1,495,000 | ||||||
Loading xslF345X05/wk-form4_1717618308.xml…